comparemela.com

Latest Breaking News On - Bellerophon therapeutics inc - Page 10 : comparemela.com

Bellerophon Therapeutics (NASDAQ:BLPH) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research report sent to investors on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Stock Performance BLPH opened at $0.04 on Friday. The company has a market capitalization of $458,737.50, a PE ratio of -0.03 […]

United-states
Bellerophon-therapeutics-inc
Renaissance-technologies
Dimensional-fund-advisors
Bellerophon-therapeutics-company-profile
Securities-exchange-commission
Geode-capital-management
Bellerophon-therapeutics
Free-report
Get-free-report
Exchange-commission

Form S-8 POS Bellerophon Therapeutics

Form S-8 POS Bellerophon Therapeutics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
New-jersey
New-york
Washington
State-of-new-jersey
Township-of-warren
Delaware
Jeffrey-schultz
Peter-fernandes
Mary-ann-cloyd
Naseem-amin
Fabian-tenenbaum

Bellerophon Therapeutics, Inc. Announces Resignation of Theodore Wang as a Member of the Company's Board

On October 12, 2023, Theodore Wang notified the board of directors of Bellerophon Therapeutics, Inc. of his resignation as a member of the Company s Board, effective immediately..

Theodore-wang
Company-board
Bellerophon-therapeutics-inc
Bellerophon-therapeutics
Markets

Bellerophon Therapeutics (NASDAQ:BLPH) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research report report published on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Trading Up 5.0 % BLPH opened at $0.38 on Thursday. The stock’s 50-day moving average price is $0.42 and its 200 day […]

United-states
Perceptive-advisors
Blackrock-inc
Bellerophon-therapeutics-inc
Acadian-asset-management
Geode-capital-management
Bellerophon-therapeutics
Free-report
Get-free-report
Asset-management
Street-corp

Analysts' New Coverage for October 5th (AAU, ACRV, AEZS, AME, APH, AWX, BGI, BLPH, BNCZF, CAKE)

Analysts’ new coverage for Thursday, October 5th: StockNews.com assumed coverage on shares of Almaden Minerals (NYSE:AAU). They issued a sell rating on the stock. Maxim Group initiated coverage on shares of Acrivon Therapeutics (NASDAQ:ACRV). They issued a buy rating and a $24.00 target price on the stock. StockNews.com assumed coverage on shares of Aeterna Zentaris […]

United-states
Argentina
America
Janney-montgomery-scott
Societe-generale
Redburn-atlantic
Sanfordc-bernstein
Stifel-nicolaus
Innsuites-hospitality-trust
Citigroup-inc
Almaden-minerals
Barclays-plc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.